Related Experiment Video
Updated: Oct 1, 2025

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Revisiting Intracavitary Immunotherapy of Cancer
Fernando Aranda1,2, Iñaki Eguren-Santamaria1,2, Ángela Bella1,2
1Immunology and Immunotherapy Research Program, Cima Universidad de Navarra, Pamplona, Navarra, Spain.
Abstract:
Ovarian cancer is often limited to the peritoneal cavity in the form of peritoneal carcinomatosis. Peritoneal spreading offers the opportunity for locoregional delivery of combinations of immunotherapy agents, maximizing bioavailability while potentially reducing systemic exposure and side effects. See related article by Orr et al., p. 2038.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...